Chen Jingde相关文献与解析，生知库 | 链接生命科学的每一步

Comparison of two omalizumab dose-reduction strategies in patients with chronic spontaneous urticaria during the control phase: standard dose maintenance therapy versus extended interval dose reduction

在对照阶段，比较两种奥马珠单抗剂量减少策略在慢性自发性荨麻疹患者中的应用：标准剂量维持治疗与延长间隔剂量减少。

期刊:American Journal of Translational Research

影响因子:1.6

doi:10.62347/VTMH9009

Zhang, Li; Chen, Jingde

麻疹

发表日期：2026

文献求助收藏

High USP32 expression contributes to cancer progression and is correlated with immune infiltrates in hepatocellular carcinoma

USP32高表达促进癌症进展，并与肝细胞癌中的免疫浸润相关。

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-023-11617-4

Xiu, Mengxi; Bao, Wenfang; Wang, Jialin; Chen, Jingde; Li, Yandong; Hai, Yanan

Preliminary experience of oral fruquintinib-capecitabine as a new maintenance treatment strategy for advanced colorectal cancer in the era of coronavirus disease 2019 (COVID-19): case report and literature review

新型冠状病毒肺炎（COVID-19）疫情期间口服呋喹替尼-卡培他滨作为晚期结直肠癌维持治疗新策略的初步经验：病例报告及文献综述

期刊:Journal of Gastrointestinal Oncology

影响因子:2

doi:10.21037/jgo-22-824

Quan, Ming; Chen, Zhiqin; Chen, Jingde; Hai, Yanan; Gao, Yong

FTO promotes cell proliferation and migration in esophageal squamous cell carcinoma through up-regulation of MMP13

FTO通过上调MMP13促进食管鳞状细胞癌细胞增殖和迁移

期刊:Experimental Cell Research

影响因子:3.3

doi:10.1016/j.yexcr.2020.111894

Shenxiang Liu, Mei Huang, Zhiqin Chen, Jingde Chen, Qian Chao, Xudong Yin, Ming Quan

Camrelizumab in advanced or metastatic solid tumour patients with DNA mismatch repair deficient or microsatellite instability high: an open-label prospective pivotal trial

卡瑞利珠单抗治疗DNA错配修复缺陷或微卫星不稳定性高的晚期或转移性实体瘤患者：一项开放标签的前瞻性关键性试验

期刊:Journal of Cancer Research and Clinical Oncology

影响因子:2.8

doi:10.1007/s00432-020-03251-5

Chen, Jingde; Quan, Ming; Chen, Zhiqin; Zeng, Tianmei; Li, Yandong; Zhou, Ying; Hai, Yanan; Gao, Yong

发表日期：2020

文献求助收藏

High sensitive detection of circulating tumor cell by multimarker lipid magnetic nanoparticles and clinical verifications

利用多标记脂质磁性纳米颗粒高灵敏度检测循环肿瘤细胞并进行临床验证

期刊:Journal of Nanobiotechnology

影响因子:12.6

doi:10.1186/s12951-019-0548-1

Chen, Jingde; Chen, Lin; Du, Shibin; Wu, Jing; Quan, Ming; Yin, Hua; Wu, Yin; Ye, Xuanting; Liang, Xiaofei; Jiang, Hong

A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation

一种新型甘草次酸修饰的奥沙利铂脂质体用于肝脏靶向治疗及体外/体内评价

期刊:Drug Design Development and Therapy

影响因子:5.1

doi:10.2147/DDDT.S81722

Chen, Jingde; Jiang, Hong; Wu, Yin; Li, Yandong; Gao, Yong

发表日期：2015

文献求助收藏

Targeting SLC6A8 suppresses tumor growth and enhances ferroptosis in hepatocellular carcinoma.

靶向 SLC6A8 可抑制肝细胞癌的肿瘤生长并增强铁死亡。

Comparison of two omalizumab dose-reduction strategies in patients with chronic spontaneous urticaria during the control phase: standard dose maintenance therapy versus extended interval dose reduction

在对照阶段，比较两种奥马珠单抗剂量减少策略在慢性自发性荨麻疹患者中的应用：标准剂量维持治疗与延长间隔剂量减少。

High USP32 expression contributes to cancer progression and is correlated with immune infiltrates in hepatocellular carcinoma

USP32高表达促进癌症进展，并与肝细胞癌中的免疫浸润相关。

Preliminary experience of oral fruquintinib-capecitabine as a new maintenance treatment strategy for advanced colorectal cancer in the era of coronavirus disease 2019 (COVID-19): case report and literature review

新型冠状病毒肺炎（COVID-19）疫情期间口服呋喹替尼-卡培他滨作为晚期结直肠癌维持治疗新策略的初步经验：病例报告及文献综述

FTO promotes cell proliferation and migration in esophageal squamous cell carcinoma through up-regulation of MMP13

FTO通过上调MMP13促进食管鳞状细胞癌细胞增殖和迁移

Camrelizumab in advanced or metastatic solid tumour patients with DNA mismatch repair deficient or microsatellite instability high: an open-label prospective pivotal trial

卡瑞利珠单抗治疗DNA错配修复缺陷或微卫星不稳定性高的晚期或转移性实体瘤患者：一项开放标签的前瞻性关键性试验

High sensitive detection of circulating tumor cell by multimarker lipid magnetic nanoparticles and clinical verifications

利用多标记脂质磁性纳米颗粒高灵敏度检测循环肿瘤细胞并进行临床验证

A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation

一种新型甘草次酸修饰的奥沙利铂脂质体用于肝脏靶向治疗及体外/体内评价